Cancer Research UK logo.
SearchDonate
  • Search

A study of nivolumab before other treatment for cancer (CA209358 Neo adjuvant group)

Overview

Cancer types:

Cervical cancer, Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasopharyngeal cancer, Non melanoma skin cancer, Skin cancer, Squamous cell skin cancer, Vaginal cancer, Vulval cancer

Status:

Closed

Phase:

Phase 1/2

Details

This study is to find out what effect giving nivolumab before surgery or chemotherapy and radiotherapy together (chemoradiotherapy) has on certain cancers.

There are 2 groups in this study

  • people who are having other anti-cancer treatment (the Neo adjuvant group)

  • people whose cancer has spread (the Metastatic group)

This summary is for the Neo adjuvant group. We have information for the Metastatic group.

Recruitment start: 1 October 2015

Recruitment end: 15 January 2020

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jeff Evans

Supported by

Bristol-Myers Squibb

Experimental Cancer Medicine Centre (ECMC)

Last reviewed: 12 Jan 2021

CRUK internal database number: 14117

Help and support